Senzime AB (publ) (STO:SEZI)
6.65
+0.05 (0.76%)
Aug 14, 2025, 4:30 PM CET
Senzime AB Revenue
Senzime AB had revenue of 25.70M SEK in the quarter ending June 30, 2025, with 72.25% growth. This brings the company's revenue in the last twelve months to 80.64M, up 71.41% year-over-year. In the year 2024, Senzime AB had annual revenue of 58.48M with 63.55% growth.
Revenue (ttm)
80.64M
Revenue Growth
+71.41%
P/S Ratio
12.87
Revenue / Employee
1.49M
Employees
54
Market Cap
1.04B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 58.48M | 22.72M | 63.55% |
Dec 31, 2023 | 35.75M | 21.72M | 154.77% |
Dec 31, 2022 | 14.03M | 3.05M | 27.81% |
Dec 31, 2021 | 10.98M | 1.64M | 17.60% |
Dec 31, 2020 | 9.34M | 2.63M | 39.13% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.31B |
Getinge AB | 35.50B |
Medicover AB | 25.22B |
Asker Healthcare Group AB | 15.88B |
Camurus AB | 2.27B |
Bonesupport Holding AB | 1.06B |
AddLife AB | 10.44B |
Senzime AB News
- 9 days ago - Senzime Secures TetraGraph Installations Across All Sites of World-Leading US Hospital System - Accesswire
- 14 days ago - New Number of Shares and Votes in Senzime AB (publ) - Accesswire
- 22 days ago - Senzime's TetraGraph System Receives Regulatory Approval in Mexico - Accesswire
- 24 days ago - Senzime AB (SNZZF) Q2 2025 Earnings Call Highlights: Robust US Growth and Strategic Investments ... - GuruFocus
- 27 days ago - Interim Report April-June 2025: 88% Growth in Local Currency - Accesswire
- 5 weeks ago - Senzime's Licensee Fukuda Denshi Expands Market Reach with Regulatory Approvals in the US and UK - Accesswire
- 5 weeks ago - Invitation to Presentation of Senzime's Second Quarter 2025 Report - Accesswire
- 6 weeks ago - Senzime Secures Major U.S. Hospital Contract for Supply and Scientific Collaboration - Accesswire